Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate—GA) are being
examined, primarily in neurological conditions involving cognitive decline. GA is a well …

This review describes the properties and activities of lipopeptides and peptide hormones
and how the lipidation of peptide hormones could potentially produce therapeutic agents …

Survivors of sepsis often develop long-term cognitive impairments. This review aimed at
exploring the results of the behavioral tools and tests which have been used to evaluate …

Aluminum is an environmentally abundant potential neurotoxic agent that may result in
oxidative damage to a range of cellular biomarkers. The potential sources of aluminum …

Abstract Copolymer-1 (Cop-1) is a peptide with immunomodulatory properties, approved by
the Food and Drug Administration of United States in the treatment of multiple sclerosis. Cop …

Microglial activation-induced neuroinflammation is closely related to the development of
sepsis-associated encephalopathy. Accumulating evidence suggests that changes in the …

Parkinson's disease (PD) is the second most common neurodegenerative disease in the
world; however, there is no cure for it. Current treatments only relieve some of the symptoms …

Rationale Major depressive disorder (MDD) is a debilitating disorder with adverse effects on
mood, memory, and quality of life. Objectives In this study, the antidepressant potential of …

The immune and nervous systems can be thought of as cognitive and plastic systems, since
they are both involved in cognition/recognition processes and can be architecturally and …

Rationale Working memory (WM) is a dynamic encoding process and an active
representation of information over a short time. The ability to guide forthcoming behavior …